Ameriprise
OSIR

Ameriprise’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Ameriprise’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-106
Closed -$1K – 5396
2014
Q3 		$1K Sell
106
-90
-46% -$1.28K ﹤0.01% 5709
2014
Q2 		$3K Sell
196
-140
-42% -$2.06K ﹤0.01% 5165
2014
Q1 		$5K Sell
336
-15
-4% -$235 ﹤0.01% 4815
2013
Q4 		$5K Sell
351
-858
-71% -$13.7K ﹤0.01% 4650
2013
Q3 		$20K Hold
1,209
– – ﹤0.01% 4437
2013
Q2 		$12K Buy
+1,209
New +$12.7K ﹤0.01% 4688

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise's OSIR Position: Q4 2014 in Review

Ameriprise sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2014, closing a stake of 106 shares — an estimated $1K sold.

Ameriprise first reported a position in OSIR in Q2 2013 and held it in 6 quarters. The position peaked at $20K in Q3 2013. 66 funds tracked by Wall St. Rank hold OSIR as of Q4 2014.

  • Ameriprise reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 106 Osiris Therapeutics, Inc. Common Stock shares in Q4 2014, an estimated $1K.
  • Ameriprise first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
  • Ameriprise's Osiris Therapeutics, Inc. Common Stock position peaked at $20K in Q3 2013.
  • 66 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.